Global Oncolytic Virus Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Report Id

45852

Publisher Name

Global Info Research

Published Date

2/18/2019

No of Pages

118

Market Scenario

Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins. Scope of the Report: Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins. The application of oncolytic virus therapy includes melanoma, prostate cancer, breast cancer, ovarian cancer and others, and the proportion of R&D Investment for melanoma in 2017 is about 34%. Market competition is intense. Amgen, Oncolytics Biotech, Viralytics, Transgene SA are the leading developers in the industry; with high investment in research marketing and they will monopoly position in the industry. The global Oncolytic Virus Therapy market is valued at 2 million USD in 2018 and is expected to reach 10 million USD by the end of 2024, growing at a CAGR of 25.8% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Oncolytic Virus Therapy. Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%. This report studies the Oncolytic Virus Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Oncolytic Virus Therapy market by product type and applications/end industries. Market Segment by Companies, this report covers Amgen Oncolytics Biotech Viralytics Transgene SA Oncolys BioPharma Targovax PsiOxus Therapeutics SillaJen Biotherapeutics Sorrento Therapeutics Lokon Pharma Genelux Corporation Vyriad TILT Biotherapeutics Cold Genesys Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers HSV-based Oncolytic Viruses Adenoviruses-based Oncolytic Viruses Vaccinia Virus-based Oncolytic Viruses Vesicular Stomatitis Virus-based Oncolytic Viruses Newcastle Disease Virus-based Oncolytic Viruses Market Segment by Applications, can be divided into Melanoma Prostate Cancer Breast Cancer Ovarian Cancer  Others

Table of Contents

Table of Contents 1 Oncolytic Virus Therapy Market Overview 1.1 Product Overview and Scope of Oncolytic Virus Therapy 1.2 Classification of Oncolytic Virus Therapy by Types 1.2.1 Global Oncolytic Virus Therapy Revenue Comparison by Types (2019-2024) 1.2.2 Global Oncolytic Virus Therapy Revenue Market Share by Types in 2018 1.2.3 HSV-based Oncolytic Viruses 1.2.4 Adenoviruses-based Oncolytic Viruses 1.2.5 Vaccinia Virus-based Oncolytic Viruses 1.2.6 Vesicular Stomatitis Virus-based Oncolytic Viruses 1.2.7 Newcastle Disease Virus-based Oncolytic Viruses 1.3 Global Oncolytic Virus Therapy Market by Application 1.3.1 Global Oncolytic Virus Therapy Market Size and Market Share Comparison by Applications (2014-2024) 1.3.2 Melanoma 1.3.3 Prostate Cancer 1.3.4 Breast Cancer 1.3.5 Ovarian Cancer  1.3.6 Others 1.4 Global Oncolytic Virus Therapy Market by Regions 1.4.1 Global Oncolytic Virus Therapy Market Size (Million USD) Comparison by Regions (2014-2024) 1.4.1 North America (USA, Canada and Mexico) Oncolytic Virus Therapy Status and Prospect (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Oncolytic Virus Therapy Status and Prospect (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oncolytic Virus Therapy Status and Prospect (2014-2024) 1.4.4 South America (Brazil, Argentina, Colombia) Oncolytic Virus Therapy Status and Prospect (2014-2024) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oncolytic Virus Therapy Status and Prospect (2014-2024) 1.5 Global Market Size of Oncolytic Virus Therapy (2014-2024) 2 Manufacturers Profiles 2.1 Amgen 2.1.1 Business Overview 2.1.2 Oncolytic Virus Therapy Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Amgen Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2017-2018) 2.2 Oncolytics Biotech 2.2.1 Business Overview 2.2.2 Oncolytic Virus Therapy Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Oncolytics Biotech Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2017-2018) 2.3 Viralytics 2.3.1 Business Overview 2.3.2 Oncolytic Virus Therapy Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Viralytics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2017-2018) 2.4 Transgene SA 2.4.1 Business Overview 2.4.2 Oncolytic Virus Therapy Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Transgene SA Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2017-2018) 2.5 Oncolys BioPharma 2.5.1 Business Overview 2.5.2 Oncolytic Virus Therapy Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Oncolys BioPharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2017-2018) 2.6 Targovax 2.6.1 Business Overview 2.6.2 Oncolytic Virus Therapy Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Targovax Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2017-2018) 2.7 PsiOxus Therapeutics 2.7.1 Business Overview 2.7.2 Oncolytic Virus Therapy Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2017-2018) 2.8 SillaJen Biotherapeutics 2.8.1 Business Overview 2.8.2 Oncolytic Virus Therapy Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2017-2018) 2.9 Sorrento Therapeutics 2.9.1 Business Overview 2.9.2 Oncolytic Virus Therapy Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2017-2018) 2.10 Lokon Pharma 2.10.1 Business Overview 2.10.2 Oncolytic Virus Therapy Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Lokon Pharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2017-2018) 2.11 Genelux Corporation 2.11.1 Business Overview 2.11.2 Oncolytic Virus Therapy Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 Genelux Corporation Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2017-2018) 2.12 Vyriad 2.12.1 Business Overview 2.12.2 Oncolytic Virus Therapy Type and Applications 2.12.2.1 Product A 2.12.2.2 Product B 2.12.3 Vyriad Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2017-2018) 2.13 TILT Biotherapeutics 2.13.1 Business Overview 2.13.2 Oncolytic Virus Therapy Type and Applications 2.13.2.1 Product A 2.13.2.2 Product B 2.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2017-2018) 2.14 Cold Genesys 2.14.1 Business Overview 2.14.2 Oncolytic Virus Therapy Type and Applications 2.14.2.1 Product A 2.14.2.2 Product B 2.14.3 Cold Genesys Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2017-2018) 3 Global Oncolytic Virus Therapy Market Competition, by Players 3.1 Global Oncolytic Virus Therapy Revenue and Share by Players (2014-2019) 3.2 Market Concentration Rate 3.2.1 Top 5 Oncolytic Virus Therapy Players Market Share 3.2.2 Top 10 Oncolytic Virus Therapy Players Market Share 3.3 Market Competition Trend 4 Global Oncolytic Virus Therapy Market Size by Regions 4.1 Global Oncolytic Virus Therapy Revenue and Market Share by Regions 4.2 North America Oncolytic Virus Therapy Revenue and Growth Rate (2014-2019) 4.3 Europe Oncolytic Virus Therapy Revenue and Growth Rate (2014-2019) 4.4 Asia-Pacific Oncolytic Virus Therapy Revenue and Growth Rate (2014-2019) 4.5 South America Oncolytic Virus Therapy Revenue and Growth Rate (2014-2019) 4.6 Middle East and Africa Oncolytic Virus Therapy Revenue and Growth Rate (2014-2019) 5 North America Oncolytic Virus Therapy Revenue by Countries 5.1 North America Oncolytic Virus Therapy Revenue by Countries (2014-2019) 5.2 USA Oncolytic Virus Therapy Revenue and Growth Rate (2014-2019) 5.3 Canada Oncolytic Virus Therapy Revenue and Growth Rate (2014-2019) 5.4 Mexico Oncolytic Virus Therapy Revenue and Growth Rate (2014-2019) 6 Europe Oncolytic Virus Therapy Revenue by Countries 6.1 Europe Oncolytic Virus Therapy Revenue by Countries (2014-2019) 6.2 Germany Oncolytic Virus Therapy Revenue and Growth Rate (2014-2019) 6.3 UK Oncolytic Virus Therapy Revenue and Growth Rate (2014-2019) 6.4 France Oncolytic Virus Therapy Revenue and Growth Rate (2014-2019) 6.5 Russia Oncolytic Virus Therapy Revenue and Growth Rate (2014-2019) 6.6 Italy Oncolytic Virus Therapy Revenue and Growth Rate (2014-2019) 7 Asia-Pacific Oncolytic Virus Therapy Revenue by Countries 7.1 Asia-Pacific Oncolytic Virus Therapy Revenue by Countries (2014-2019) 7.2 China Oncolytic Virus Therapy Revenue and Growth Rate (2014-2019) 7.3 Japan Oncolytic Virus Therapy Revenue and Growth Rate (2014-2019) 7.4 Korea Oncolytic Virus Therapy Revenue and Growth Rate (2014-2019) 7.5 India Oncolytic Virus Therapy Revenue and Growth Rate (2014-2019) 7.6 Southeast Asia Oncolytic Virus Therapy Revenue and Growth Rate (2014-2019) 8 South America Oncolytic Virus Therapy Revenue by Countries 8.1 South America Oncolytic Virus Therapy Revenue by Countries (2014-2019) 8.2 Brazil Oncolytic Virus Therapy Revenue and Growth Rate (2014-2019) 8.3 Argentina Oncolytic Virus Therapy Revenue and Growth Rate (2014-2019) 8.4 Colombia Oncolytic Virus Therapy Revenue and Growth Rate (2014-2019) 9 Middle East and Africa Revenue Oncolytic Virus Therapy by Countries 9.1 Middle East and Africa Oncolytic Virus Therapy Revenue by Countries (2014-2019) 9.2 Saudi Arabia Oncolytic Virus Therapy Revenue and Growth Rate (2014-2019) 9.3 UAE Oncolytic Virus Therapy Revenue and Growth Rate (2014-2019) 9.4 Egypt Oncolytic Virus Therapy Revenue and Growth Rate (2014-2019) 9.5 Nigeria Oncolytic Virus Therapy Revenue and Growth Rate (2014-2019) 9.6 South Africa Oncolytic Virus Therapy Revenue and Growth Rate (2014-2019) 10 Global Oncolytic Virus Therapy Market Segment by Type 10.1 Global Oncolytic Virus Therapy Revenue and Market Share by Type (2014-2019) 10.2 Global Oncolytic Virus Therapy Market Forecast by Type (2019-2024) 10.3 HSV-based Oncolytic Viruses Revenue Growth Rate (2014-2024) 10.4 Adenoviruses-based Oncolytic Viruses Revenue Growth Rate (2014-2024) 10.5 Vaccinia Virus-based Oncolytic Viruses Revenue Growth Rate (2014-2024) 10.6 Vesicular Stomatitis Virus-based Oncolytic Viruses Revenue Growth Rate (2014-2024) 10.7 Newcastle Disease Virus-based Oncolytic Viruses Revenue Growth Rate (2014-2024) 11 Global Oncolytic Virus Therapy Market Segment by Application 11.1 Global Oncolytic Virus Therapy Revenue Market Share by Application (2014-2019) 11.2 Oncolytic Virus Therapy Market Forecast by Application (2019-2024) 11.3 Melanoma Revenue Growth (2014-2019) 11.4 Prostate Cancer Revenue Growth (2014-2019) 11.5 Breast Cancer Revenue Growth (2014-2019) 11.6 Ovarian Cancer  Revenue Growth (2014-2019) 11.7 Others Revenue Growth (2014-2019) 12 Global Oncolytic Virus Therapy Market Size Forecast (2019-2024) 12.1 Global Oncolytic Virus Therapy Market Size Forecast (2019-2024) 12.2 Global Oncolytic Virus Therapy Market Forecast by Regions (2019-2024) 12.3 North America Oncolytic Virus Therapy Revenue Market Forecast (2019-2024) 12.4 Europe Oncolytic Virus Therapy Revenue Market Forecast (2019-2024) 12.5 Asia-Pacific Oncolytic Virus Therapy Revenue Market Forecast (2019-2024) 12.6 South America Oncolytic Virus Therapy Revenue Market Forecast (2019-2024) 12.7 Middle East and Africa Oncolytic Virus Therapy Revenue Market Forecast (2019-2024) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

Methodology

This research report involves complete picture of the market with the help of in-depth secondary and primary research. This research report studies several aspects of the market and analyze vital industry influencers. Extensive secondary research has been conducted using paid as well as open access data sources in order to gather information on the market and parent market. These key findings are then analyzed and validated with the help of in-house data models and primary discussions with key industry participants and experts across the value chain

research-methodology

Research Tools and Models

  • Top-Down Approach and Bottom-Up Approach
  • QFD Modeling for Market Size and Share Calculation
  • Regression, Variable and Impact Analysis
  • Penetration Modeling

Qualitative Research

  • It comprises briefing about market dynamics and business opportunities and strategies.
  • Finally, all the research findings are validated through interviews with in-house industry experts, freelance consultants and key opinion leaders etc.

Quantitative Research

It involves various mathematical tools, models, projection, and sampling techniques. It involves following steps:

  • Identification of market variables and market size derivation
  • Assessment of future prospects, opportunities and market penetration rates by analyzing product commercialization, regional trends etc.
  • Evaluation historical market trends and derivation of present and future year-on-year growth trends

Fill below details to get free sample !!

Contact Us
Call Now